Proactively manage your pharmacy inventory
Find generic entry opportunities
Drug patents …
… from Kazakhstan to Kalamazoo
Manage your formulary budget
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Anticipate generic drug launch
Flat-rate pricing for predictable budgeting
Short-term plans for project- or client-based billing
|Title:||2'-fluoro-arabinofuranosyl purine nucleosides|
|Abstract:||2'-Deoxy-2'-fluoro-.beta.-D-arabinofuranosyl nucleosides of the following structure are disclosed: ##STR1## wherein X and Y are the same or different and are hydrogen, OR.sup.3, SR.sup.3, NR.sup.3 N.sup.4 or NHacyl wherein R.sup.3 and R.sup.4 are the same or different and are hydrogen, lower alkyl of 1 to 7 carbon atoms, aralkyl, or aryl; NHacyl is alkanoyl or aroylamide; R.sup.1 and R.sup.2 are the same or different and are hydrogen, acyl or aroyl.|
|Inventor(s):||Watanabe; Kyoichi A. (Rye Brook, NY), Chu; Chung K. (Athens, GA), Fox; Jack J. (White Plains, NY)|
|Assignee:||Sloan-Kettering Institute for Cancer Research (New York, NY)|
Patent Claim Types:|
see list of patent claims
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|Germany||3687397||<disabled in preview>|
|Germany||122006000056||<disabled in preview>|
|European Patent Office||0219829||<disabled in preview>||06C0029||France||<disabled>|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.